Guillaume Pare Selected Research

Hemorrhage

1/2021	Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials.
7/2020	Bleeding risks for uncharacterized platelet function disorders.
6/2018	Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillaume Pare Research Topics

Disease

12	Stroke (Strokes) 05/2022 - 05/2008
11	Opioid-Related Disorders (Opiate Addiction) 01/2017 - 01/2014
7	Myocardial Infarction 11/2020 - 05/2008
7	Substance-Related Disorders (Drug Abuse) 01/2020 - 01/2014
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 04/2007
5	Ischemic Stroke 05/2022 - 08/2016
4	Hypertension (High Blood Pressure) 01/2022 - 04/2009
4	Embolic Stroke 01/2020 - 09/2016
4	Pain (Aches) 04/2015 - 01/2014
3	Hemorrhage 01/2021 - 06/2018
3	Acute Coronary Syndrome 01/2021 - 11/2016
3	Coronary Disease (Coronary Heart Disease) 11/2020 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 10/2019 - 01/2012
3	Chronic Pain 04/2015 - 01/2014
2	Thrombosis (Thrombus) 11/2020 - 05/2008
2	Mental Disorders (Mental Disorder) 01/2020 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2019 - 01/2013
2	Embolism (Embolus) 06/2018 - 09/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 11/2016
2	Angioedema 09/2013 - 09/2013
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 05/2008
2	Neoplasms (Cancer) 07/2012 - 07/2012
2	Insulin Resistance 01/2012 - 05/2008
1	Dementia (Dementias) 01/2022
1	Cognitive Dysfunction 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Frailty 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2020
1	Rupture 11/2020
1	Critical Illness (Critically Ill) 09/2020
1	COVID-19 09/2020
1	Opiate Overdose 01/2020
1	Pathologic Constriction (Stenosis) 06/2018
1	Intracranial Embolism 06/2018
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 04/2017
1	Neuroferritinopathy 03/2017
1	Hemochromatosis (Bronze Diabetes) 03/2017
1	Iron Overload 03/2017
1	ATR-X syndrome 01/2017

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2008
11	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2014
10	Methadone (Dolophine)FDA LinkGeneric 01/2017 - 01/2014
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2008
5	Pharmaceutical PreparationsIBA 10/2019 - 09/2013
4	RivaroxabanIBA 01/2020 - 09/2016
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 09/2016
3	ApolipoproteinsIBA 05/2022 - 05/2008
3	LipidsIBA 05/2022 - 01/2013
3	C-Reactive ProteinIBA 01/2020 - 05/2008
3	Troponin T (Troponin T1)IBA 01/2020 - 03/2014
3	TroponinIBA 02/2017 - 03/2014
3	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 02/2010
3	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2017 - 01/2014
2	Apolipoproteins B (ApoB)IBA 05/2022 - 08/2016
2	factor V LeidenIBA 01/2021 - 11/2020
2	ORALIT (ORS)IBA 07/2020 - 10/2019
2	Lipoprotein(a)IBA 05/2019 - 03/2019
2	Factor Xa InhibitorsIBA 06/2018 - 09/2016
2	Factor Xa (Coagulation Factor Xa)IBA 06/2018 - 09/2016
2	LDL CholesterolIBA 01/2017 - 08/2010
2	Clopidogrel (Plavix)FDA Link 11/2016 - 11/2012
2	Biological ProductsIBA 09/2016 - 01/2015
2	Testosterone (Sustanon)FDA Link 04/2015 - 08/2014
2	Ramipril (Altace)FDA LinkGeneric 01/2014 - 09/2013
2	Telmisartan (Micardis)FDA Link 01/2014 - 09/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2013 - 09/2013
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2013 - 09/2013
2	HomocysteineIBA 09/2013 - 04/2009
2	HDL CholesterolIBA 08/2010 - 04/2007
1	Lipoproteins (Lipoprotein)IBA 05/2022
1	oxidized low density lipoproteinIBA 05/2022
1	Insulin Glargine (Lantus)FDA Link 01/2022
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	UromodulinIBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	InterleukinsIBA 09/2020
1	ChemokinesIBA 09/2020
1	ProteomeIBA 09/2020
1	CollagenIBA 07/2020
1	trans-crotonin (CTN)IBA 01/2020
1	AnticoagulantsIBA 06/2018
1	Cadherins (E-Cadherin)IBA 04/2017
1	IronIBA 03/2017
1	Transferrin (beta 2 Transferrin)IBA 03/2017
1	Ferritins (Ferritin)IBA 03/2017
1	ApoferritinsIBA 03/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2017
1	ChromatinIBA 01/2017
1	PCSK9 InhibitorsIBA 01/2017
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017

Therapy/Procedure

8	Therapeutics 01/2021 - 07/2012
2	Precision Medicine 01/2021 - 09/2013
2	Secondary Prevention 01/2020 - 09/2016
2	Opiate Substitution Treatment 04/2015 - 09/2014